Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome.

La Manna G, Corsini S, Iannelli S, Cappuccilli ML, Comai G, Iorio M, Todeschini P, Carretta E, Scolari MP, Bontadini A, Stefoni S.

Ann Transplant. 2013 Nov 13;18:611-21. doi: 10.12659/AOT.889157.

PMID:
24220609
2.

KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation.

Hanvesakul R, Kubal C, Moore J, Neil D, Cook M, Ball S, Briggs D, Moss P, Cockwell P.

PLoS One. 2011;6(8):e23631. doi: 10.1371/journal.pone.0023631. Epub 2011 Aug 31.

PMID:
21912600
3.

Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.

Vampa ML, Norman PJ, Burnapp L, Vaughan RW, Sacks SH, Wong W.

Transplantation. 2003 Oct 27;76(8):1220-8.

PMID:
14578757
4.

[Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].

Bao XJ, He J, Chen ZX, Wu DP, Yao L, Yuan XN, Cen JN, Qiu QC, Di WY, Zhang H, Zhang J, Zhou XH, Xu HX.

Zhonghua Xue Ye Xue Za Zhi. 2007 Aug;28(8):510-3. Chinese.

PMID:
18078124
5.

Killer cell immunoglobulin-like receptor polymorphisms in HLA-identical kidney transplant recipients: lack of 2DL2 and 2DS2 may be associated with poor graft function.

Cirocco RE, Mathew JM, Burke GW 3rd, Esquenazi V, Miller J.

Tissue Antigens. 2007 Apr;69 Suppl 1:123-4.

PMID:
17445184
6.

Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.

Symons HJ, Leffell MS, Rossiter ND, Zahurak M, Jones RJ, Fuchs EJ.

Biol Blood Marrow Transplant. 2010 Apr;16(4):533-42. doi: 10.1016/j.bbmt.2009.11.022. Epub 2009 Dec 2.

PMID:
19961944
7.

KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.

Legaz I, López-Álvarez MR, Campillo JA, Moya-Quiles MR, Bolarín JM, de la Peña J, Salgado G, Gimeno L, García-Alonso AM, Muro M, Miras M, Alonso C, Álvarez-López MR, Minguela A.

Transplantation. 2013 Apr 27;95(8):1037-44. doi: 10.1097/TP.0b013e318286486c.

PMID:
23478359
8.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

PMID:
19326408
9.

[Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation].

Liang ZY, Ren HY, Cen XN, Qiu ZX, Wang LH, Ou JP, Li Y, Wang MJ, Wang WS, Xu WL, Dong YJ, Yin Y, Sun YH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):155-60. doi: 10.7534/j.issn.1009-2137.2013.01.032. Chinese.

PMID:
23484711
10.

Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.

Moroso V, van der Meer A, Tilanus HW, Kazemier G, van der Laan LJ, Metselaar HJ, Joosten I, Kwekkeboom J.

Transpl Int. 2011 Sep;24(9):932-42. doi: 10.1111/j.1432-2277.2011.01286.x. Epub 2011 Jun 14.

PMID:
21672051
11.

Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.

Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P.

Blood. 2003 May 1;101(9):3730-40. Epub 2003 Jan 2.

PMID:
12511415
12.

No impact of KIR-ligand mismatch on allograft outcome in HLA-compatible kidney transplantation.

Tran TH, Unterrainer C, Fiedler G, Döhler B, Scherer S, Ruhenstroth A, Adamek M, Middleton D, Opelz G.

Am J Transplant. 2013 Apr;13(4):1063-8. doi: 10.1111/ajt.12134. Epub 2013 Feb 7.

PMID:
23398855
13.

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

Wang H, Zhai WJ, Wang HH, He Y, Zhou Z, Zhao YX, Zhai WH, Zhang RL, Wang M, Feng SZ, Han MZ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Oct;31(5):533-7. Chinese.

PMID:
19968064
14.

KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.

Michelo CM, van der Meer A, Tijssen HJ, Zomer R, Stelma F, Hilbrands LB, Joosten I.

Transplantation. 2015 Jul;99(7):1506-13. doi: 10.1097/TP.0000000000000497.

PMID:
25427165
15.

HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.

Fosby B, Næss S, Hov JR, Traherne J, Boberg KM, Trowsdale J, Foss A, Line PD, Franke A, Melum E, Scott H, Karlsen TH.

World J Gastroenterol. 2014 Apr 14;20(14):3986-4000. doi: 10.3748/wjg.v20.i14.3986.

PMID:
24744588
16.
17.

NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Björklund AT, Schaffer M, Fauriat C, Ringdén O, Remberger M, Hammarstedt C, Barrett AJ, Ljungman P, Ljunggren HG, Malmberg KJ.

Blood. 2010 Apr 1;115(13):2686-94. doi: 10.1182/blood-2009-07-229740. Epub 2010 Jan 22.

PMID:
20097883
18.

Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation.

Nowak I, Magott-Procelewska M, Kowal A, Miazga M, Wagner M, Niepiekło-Miniewska W, Kamińska M, Wiśniewski A, Majorczyk E, Klinger M, Łuszczek W, Pawlik A, Płoski R, Barcz E, Senitzer D, Kuśnierczyk P.

PLoS One. 2012;7(9):e44718. doi: 10.1371/journal.pone.0044718. Epub 2012 Sep 13.

PMID:
23028591
19.
20.

Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.

Zhao XY, Huang XJ, Liu KY, Xu LP, Liu DH.

Eur J Haematol. 2007 Apr;78(4):338-46.

PMID:
17378893
Items per page

Supplemental Content

Write to the Help Desk